Jared Kaltwasser

Driven by his twin passions for music and science, Louis M. Staudt, MD, PhD, has made a career out of reading between the notes.

Five years since the first FDA approval of CAR T-cell therapy in relapsed/refractory lymphoma, there is still much to learn about how to optimize its use, according to Sattva S. Neelapu, MD.

Walter J. Curran Jr, MD, always had the potential to be an overachiever, but his sense of discipline turned that potential into reality.